Results 131 to 140 of about 67,580 (201)

Editorial Expression of Concern: Two novel human anti-ErbB2 immunoagents are active on trastuzumab-resistant tumours. [PDF]

Br J Cancer
Gelardi T, Damiano V, Rosa R, Bianco R, Cozzolino R, Tortora G, Laccetti P, D'Alessio G, De Lorenzo C.   +8 more
europepmc   +1 more source

Protocol for a non-inferiority randomized controlled trial of spontaneous breathing trial in children with and without pressure support. [PDF]

Crit Care Sci
Colleti Junior J, Araujo OR, Weber KT, Santos GMVD, Silva DCBD, Volpon LC, Carlotti APCP.   +6 more
europepmc   +1 more source

Pathogenic MAX Variant in Bilateral Adrenal Paragangliomas: The Dilemma of Cortical-Sparing Surgery. [PDF]

Cureus
Carmona Alexandrino H, Martins Fernandes A, Godinho R, Castelo Branco N, Martins R.   +4 more
europepmc   +1 more source

Meet-URO Score Validation in Real-world Patients with Metastatic Renal Cell Carcinoma Receiving First-line Pembrolizumab Plus axitinib: A Subanalysis of the Prospective ProPAXI Study. [PDF]

J Kidney Cancer VHL
Airò G, Guida A, Gili A, Signori A, Rebuzzi SE, Maruzzo M, Lai E, Pierantoni F, Bimbatti D, Basso U, Damassi A, Calabrò F, Cerbone L, Caserta C, Sirgiovanni G, Serafin D, Caffo O, Scagliarini S, Bracarda S, Buti S.   +19 more
europepmc   +1 more source

Metastatic Mammary-Like Adenocarcinoma of the Vulva Responding to Cyclin-Dependent Kinase (CDK) Inhibitor: A Case Report and Literature Review. [PDF]

Cureus
Pereira F, Pimenta JL, Rei M, Dias CR, Pereira D.   +4 more
europepmc   +1 more source

[Teratoid Wilms tumor in an adult: A case report]. [PDF]

Rev Med Inst Mex Seguro Soc
Hernández-Marchena YN, González-Medina WE, Bolado-García PB, Surur-Zaibak EE, Balderas YO, Hernández-Valadez OF, Marrufo-Solís V, Luna HDL, García-Saury K, Méndez-Gutierrez J.   +9 more
europepmc   +1 more source

Response to trastuzumab-deruxtecan in metastatic triple-negative breast cancer with both HER2 mutation and low expression. [PDF]

Einstein (Sao Paulo)
Amarger CD, Rabello MIS, Skaf SC, Moura F, Cassoli JPB, Taranto P, Serrano Usón Junior PL, Kaliks R, Beal JR.   +8 more
europepmc   +1 more source

Adjuvant atezolizumab in surgically resected NSCLC patients with PD-L1 expression ≥ 50%: real-world data from the Italian ATLAS registry. [PDF]

Oncologist
Passiglia F, Reale ML, Pasello G, Viscardi G, Attili I, Mazzoni F, Galetta D, Catania C, Andrikou K, Russo A, Vavala T, Bulotta A, Calvetti L, Carta AM, Grisanti S, Mariotti S, La Cava G, Dodi A, Scotti V, Del Giudice T, Minuti G, Pizzutillo EG, Chiari R, Della Corte CM, Genova C, Lo Russo G, Pignataro D, Pozzessere D, Roca E, Toschi L, Bennati C, Borra G, Bettini A, Favaretto A, Gelibter A, Gori S, Tabbò F, Pagano M, Pavan A, Belluomini L, Tondulli L, Sergi C, Stanzione B, Malapelle U, Novello S, Bria E.   +45 more
europepmc   +1 more source

MOLECULAR ANALYSIS OF BRCA1/2 GENES AND MULTIGENE-PANEL TESTING IN SICILIAN TRIPLE NEGATIVE BREAST CANCER [PDF]

Barraco N., Bazan V., Bono M., Calò V., CANCELLIERE, Daniela, Castiglia M., CUCINELLA, Alessandra, CUTAIA, Sofia, Fanale D., Fiorino A., LISANTI, Maria Chiara, Listì A., Pivetti A., Russo A.   +13 more
core  

Rapidly Progressive Cerebellar Syndrome Associated With Anti-Yo Antibodies Following Complete Response to Advanced Ovarian Carcinoma Treated With Olaparib: A Case Report. [PDF]

Cureus
Carvalho S, Lopes AC, Lopes AR.
europepmc   +1 more source